Abstract
The independent association of diabetes and hyperglycemia on the outcomes of sepsis remains unclear. We conducted retrospective cohort analyses of outcomes among patients with community-onset sepsis admitted to Shamir Medical Center, Israel (08-12/2016). Statistical associations were queried by Cox and logistic regressions, controlled for by matched propensity score analyses. Among 1527 patients with community-onset sepsis, 469 (30.7%) were diabetic. Diabetic patients were significantly older, with advanced complexity of comorbidities, and were more often exposed to healthcare environments. Despite statistically significant univariable associations with in-hospital and 90-day mortality, the adjusted Hazard Ratios (aHR) were 1.21 95% CI 0.8–1.71, p = 0.29 and 1.13 95% CI 0.86–1.49, p = 0.37, respectively. However, hyperglycemia at admission (i.e., above 200 mg/dl (was independently associated with: increased in-hospital mortality, aHR 1.48 95% CI 1.02–2.16, p = 0.037, 30-day mortality, aHR 1.8 95% CI 1.12–2.58, p = 0.001), and 90-day mortality, aHR 1.68 95% CI 1.24–2.27, p = 0.001. This association was more robust among diabetic patients than those without diabetes. In this study, diabetes was not associated with worse clinical outcomes in community-onset sepsis. However, high glucose levels at sepsis onset are independently associated with a worse prognosis, particularly among diabetic patients. Future trials should explore whether glycemic control could impact the outcomes and should be part of the management of sepsis, among the general adult septic population.
Similar content being viewed by others
References
Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE (2017) IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 128:40–50. https://doi.org/10.1016/j.diabres.2017.03.024
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303–1310. https://doi.org/10.1097/00003246-200107000-00002
Mayr FB, Yende S, Angus DC (2014) Epidemiology of severe sepsis. Virulence 5(1):4–11. https://doi.org/10.4161/viru.27372
Shah BR, Hux JE (2003) Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 26(2):510–513. https://doi.org/10.2337/diacare.26.2.510
Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njolstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J, Emerging Risk Factors C (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364(9):829–841. https://doi.org/10.1056/NEJMoa1008862
Schuetz P, Castro P, Shapiro NI (2011) Diabetes and sepsis: preclinical findings and clinical relevance. Diabetes Care 34(3):771–778. https://doi.org/10.2337/dc10-1185
Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulme R, Lepage E, Le Gall R (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28(2):108–121. https://doi.org/10.1007/s00134-001-1143-z
Kornum JB, Thomsen RW, Riis A, Lervang HH, Schonheyder HC, Sorensen HT (2008) Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care 31(8):1541–1545. https://doi.org/10.2337/dc08-0138
Pearson-Stuttard J, Blundell S, Harris T, Cook DG, Critchley J (2016) Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol 4(2):148–158. https://doi.org/10.1016/S2213-8587(15)00379-4
Stegenga ME, van der Crabben SN, Blumer RM, Levi M, Meijers JC, Serlie MJ, Tanck MW, Sauerwein HP, van der Poll T (2008) Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 112(1):82–89. https://doi.org/10.1182/blood-2007-11-121723
Foss-Freitas MC, Foss NT, Donadi EA, Foss MC (2008) Effect of the glycemic control on intracellular cytokine production from peripheral blood mononuclear cells of type 1 and type 2 diabetic patients. Diabetes Res Clin Pract 82(3):329–334. https://doi.org/10.1016/j.diabres.2008.09.003
Bertoni AG, Saydah S, Brancati FL (2001) Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care 24(6):1044–1049. https://doi.org/10.2337/diacare.24.6.1044
Kabeya Y, Shimada A, Tsukada N, Atsumi Y, Higaki M (2016) Diabetes affects length of stay and hospital costs for elderly patients with pneumonia: an analysis of a hospital administrative database. Tokai J Exp Clin Med 41(4):203–209
van Vught LA, Holman R, de Jonge E, de Keizer NF, van der Poll T (2017) Diabetes is not associated with increased 90-day mortality risk in critically ill patients with sepsis. Crit Care Med 45(10):e1026–e1035. https://doi.org/10.1097/CCM.0000000000002590
Esper AM, Moss M, Martin GS (2009) The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study. Crit Care 13(1):R18. https://doi.org/10.1186/cc7717
Trevelin SC, Carlos D, Beretta M, da Silva JS, Cunha FQ (2017) Diabetes mellitus and sepsis: a challenging association. Shock 47(3):276–287. https://doi.org/10.1097/SHK.0000000000000778
Moss M, Guidot DM, Steinberg KP, Duhon GF, Treece P, Wolken R, Hudson LD, Parsons PE (2000) Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med 28(7):2187–2192. https://doi.org/10.1097/00003246-200007000-00001
Kang L, Han J, Yang QC, Huang HL, Hao N (2015) Effects of different blood glucose levels on critically ill patients in an intensive care unit. J Mol Microbiol Biotechnol 25(6):388–393. https://doi.org/10.1159/000441655
Koyfman L, Brotfain E, Erblat A, Kovalenko I, Reina YY, Bichovsky Y, Borer A, Friger M, Frenkel A, Klein M (2018) The impact of the blood glucose levels of non-diabetic critically ill patients on their clinical outcome. Anaesthesiol Intensive Ther 50(1):20–26. https://doi.org/10.5603/AIT.2018.0004
Akirov A, Elis A (2016) The prognostic significance of admission blood glucose levels in patients with urinary tract infection. Diabetes Res Clin Pract 115:99–105. https://doi.org/10.1016/j.diabres.2016.01.025
Furukawa M, Kinoshita K, Yamaguchi J, Hori S, Sakurai A (2019) Sepsis patients with complication of hypoglycemia and hypoalbuminemia are an early and easy identification of high mortality risk. Intern Emerg Med 14(4):539–548. https://doi.org/10.1007/s11739-019-02034-2
Falcone M, Tiseo G, Russo A, Giordo L, Manzini E, Bertazzoni G, Palange P, Taliani G, Cangemi R, Farcomeni A, Vullo V, Violi F, Venditti M (2016) Hospitalization for pneumonia is associated with decreased 1-year survival in patients with type 2 diabetes: results from a prospective cohort study. Medicine (Baltimore) 95(5):e2531. https://doi.org/10.1097/MD.0000000000002531
Friedman ND, Levit D, Taleb E, Marcus G, Michaeli L, Broide M, Mengesha B, Zaidenstein R, Lazarovitch T, Dadon M, Kaye KS, Marchaim D (2018) Towards a definition for health care-associated infection. Open Forum Infect Dis 5(6):ofy116. https://doi.org/10.1093/ofid/ofy116
Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791–797. https://doi.org/10.7326/0003-4819-137-10-200211190-00007
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810. https://doi.org/10.1001/jama.2016.0287
McGrade P, Yang S, Nugent K (2019) The association between admission glucose levels and outcomes in adults admitted to a tertiary care hospital. J Community Hosp Intern Med Perspect 9(3):195–202. https://doi.org/10.1080/20009666.2019.1611318
Sotello D, Yang S, Nugent K (2019) Glucose and lactate levels at admission as predictors of in-hospital mortality. Cureus 11(10):e6027. https://doi.org/10.7759/cureus.6027
Kutz A, Struja T, Hausfater P, Amin D, Amin A, Haubitz S, Bernard M, Huber A, Mueller B, Schuetz P, group Ts (2017) The association of admission hyperglycaemia and adverse clinical outcome in medical emergencies: the multinational, prospective, observational TRIAGE study. Diabet Med 34(7):973–982. https://doi.org/10.1111/dme.13325
Dungan KM, Braithwaite SS, Preiser JC (2009) Stress hyperglycaemia. Lancet 373(9677):1798–1807. https://doi.org/10.1016/S0140-6736(09)60553-5
https://www.cdc.gov/nhsn/xls/master-organism-com-commensals-lists.xlsx. Accessed Jan 2020
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281. https://doi.org/10.1111/j.1469-0691.2011.03570.x
Leclercq R, Canton R, Brown DF, Giske CG, Heisig P, MacGowan AP, Mouton JW, Nordmann P, Rodloff AC, Rossolini GM, Soussy CJ, Steinbakk M, Winstanley TG, Kahlmeter G (2013) EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 19(2):141–160. https://doi.org/10.1111/j.1469-0691.2011.03703.x
Cecconi M, Evans L, Levy M, Rhodes A (2018) Sepsis and septic shock. Lancet 392(10141):75–87. https://doi.org/10.1016/S0140-6736(18)30696-2
Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ (2014) Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med 174(2):251–258. https://doi.org/10.1001/jamainternmed.2013.12956
Kanafani ZA, Kourany WM, Fowler VG Jr, Levine DP, Vigliani GA, Campion M, Katz DE, Corey GR, Boucher HW (2009) Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis. Eur J Clin Microbiol Infect Dis 28(12):1477–1482. https://doi.org/10.1007/s10096-009-0808-3
Torres A, Peetermans WE, Viegi G, Blasi F (2013) Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax 68(11):1057–1065. https://doi.org/10.1136/thoraxjnl-2013-204282
Chao HY, Liu PH, Lin SC, Chen CK, Chen JC, Chan YL, Wu CC, Blaney GN, Liu ZY, Wu CJ, Chen KF (2017) Association of in-hospital mortality and dysglycemia in septic patients. PLoS ONE 12(1):e0170408. https://doi.org/10.1371/journal.pone.0170408
Schuetz P, Jones AE, Howell MD, Trzeciak S, Ngo L, Younger JG, Aird W, Shapiro NI (2011) Diabetes is not associated with increased mortality in emergency department patients with sepsis. Ann Emerg Med 58(5):438–444. https://doi.org/10.1016/j.annemergmed.2011.03.052
Michalopoulos A, Falagas ME, Karatza DC, Alexandropoulou P, Papadakis E, Gregorakos L, Chalevelakis G, Pappas G (2011) Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant gram-negative primary bacteremia of critically ill patients. Am J Infect Control 39(5):396–400. https://doi.org/10.1016/j.ajic.2010.06.017
Pogue JM, Kaye KS, Cohen DA, Marchaim D (2015) Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens. Clin Microbiol Infect 21(4):302–312. https://doi.org/10.1016/j.cmi.2014.12.025
Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L (2010) Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 54(11):4851–4863. https://doi.org/10.1128/AAC.00627-10
Grondman I, Pirvu A, Riza A, Ioana M, Netea MG (2020) Biomarkers of inflammation and the etiology of sepsis. Biochem Soc Trans 48(1):1–14. https://doi.org/10.1042/BST20190029
Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P, Torremocha F, Herpin D, Marechaud R (2004) Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med 21(4):305–310. https://doi.org/10.1111/j.1464-5491.2004.01112.x
Di Carlo A, Lamassa M, Franceschini M, Bovis F, Cecconi L, Pournajaf S, Paravati S, Biggeri A, Inzitari D, Ferro S, Italian Study Group on Implementation of Stroke C (2018) Impact of acute-phase complications and interventions on 6-month survival after stroke. A prospective observational study. PLoS ONE 13(3):e0194786. https://doi.org/10.1371/journal.pone.0194786
van Vught LA, Wiewel MA, Klein Klouwenberg PM, Hoogendijk AJ, Scicluna BP, Ong DS, Cremer OL, Horn J, Bonten MM, Schultz MJ, van der Poll T, Molecular D, Risk Stratification of Sepsis C (2016) Admission hyperglycemia in critically ill sepsis patients: association with outcome and host response. Crit Care Med 44(7):1338–1346. https://doi.org/10.1097/CCM.0000000000001650
Hoang QN, Pisani MA, Inzucchi S, Hu B, Honiden S (2014) The prevalence of undiagnosed diabetes mellitus and the association of baseline glycemic control on mortality in the intensive care unit: a prospective observational study. J Crit Care 29(6):1052–1056. https://doi.org/10.1016/j.jcrc.2014.06.007
Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW (2013) Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med 368(17):1613–1624. https://doi.org/10.1056/NEJMsa1213829
Plummer MP, Bellomo R, Cousins CE, Annink CE, Sundararajan K, Reddi BA, Raj JP, Chapman MJ, Horowitz M, Deane AM (2014) Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Intensive Care Med 40(7):973–980. https://doi.org/10.1007/s00134-014-3287-7
Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M (2011) The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 39(1):105–111. https://doi.org/10.1097/CCM.0b013e3181feb5ea
Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36(1):8–27
Funding
The authors received no funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have nothing to declare.
Ethical approval
The study was approved by the local ethics (Helsinki) committee prior to its initiation.
Consent to participate
Due to its retrospective nature no consent was necessary.
Consent for publication
All authors give their consent for publication.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zohar, Y., Zilberman Itskovich, S., Koren, S. et al. The association of diabetes and hyperglycemia with sepsis outcomes: a population-based cohort analysis. Intern Emerg Med 16, 719–728 (2021). https://doi.org/10.1007/s11739-020-02507-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-020-02507-9